Serine protease HtrA1 accumulates in corneal transforming growth factor beta induced protein (TGFBIp) amyloid deposits

Molecular Vision

Volumn 19, Issue , 2013, Pages 861-876

  Karring, Henrik ^a   Poulsen, Ebbe Toftgaard ^b   Runager, Kasper ^b   Thøgersen, Ida B ^b   Klintworth, Gordon K ^c   Højrup, Peter ^a   Enghild, Jan Johannes ^b  

^a UNIVERSITY OF SOUTHERN DENMARK   (Denmark)

^b AARHUS UNIVERSITY   (Denmark)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID P COMPONENT; AMYLOID PROTEIN; APOLIPOPROTEIN A4; CLUSTERIN; FASCICLIN 1 DOMAIN 4; FASCICLIN I; KALLIKREIN; KALLIKREIN 14; SERINE PROTEINASE; SERINE PROTEINASE HTRA1; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA INDUCED PROTEIN; UNCLASSIFIED DRUG;

AGED; AMINO ACID SEQUENCE; AMYLOIDOSIS; ARTICLE; CARBOXY TERMINAL SEQUENCE; CASE REPORT; CORNEA AMYLOIDOSIS; CORNEA DISEASE; CORNEA DYSTROPHY; CORNEA STROMA; ENZYME ACTIVITY; FEMALE; GENE; GENE MUTATION; HETEROZYGOTE; HUMAN; HUMAN TISSUE; LASER CAPTURE MICRODISSECTION; LATTICE CORNEAL DYSTROPHY TYPE 1; LIQUID CHROMATOGRAPHY; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN CLEAVAGE; PROTEIN DEGRADATION; PROTEOMICS; RATING SCALE; TANDEM MASS SPECTROMETRY; TGFBI GENE;

AGED; AMINO ACID SEQUENCE; CLUSTER ANALYSIS; CORNEA; CORNEAL DYSTROPHIES, HEREDITARY; CORNEAL STROMA; EXTRACELLULAR MATRIX PROTEINS; FEMALE; HUMANS; MICRODISSECTION; MOLECULAR SEQUENCE DATA; PLAQUE, AMYLOID; PROTEASE INHIBITORS; PROTEIN STRUCTURE, TERTIARY; PROTEOLYSIS; PROTEOMICS; SEQUENCE ALIGNMENT; SERINE ENDOPEPTIDASES; TANDEM MASS SPECTROMETRY; TRANSFORMING GROWTH FACTOR BETA; TRYPSIN;

EID: 84876269906     PISSN: None     EISSN: 10900535     Source Type: Journal    
DOI: None     Document Type: Article

References (63)

1. Munier FL, Korvatska E, Djemai A, Le Paslier D, Zografos L, Pescia G, Schorderet DF. Kerato-epithelin mutations in four 5q31-linked corneal dystrophies. Nat Genet 1997; 15:247-51. [PMID: 9054935].
2. Klintworth GK. Corneal dystrophies. Orphanet J Rare Dis 2009; 4:7-[PMID: 19236704].
3. Runager K, Basaiawmoit RV, Deva T, Andreasen M, Valnickova Z, Sørensen CS, Karring H, Thøgersen IB, Christiansen G, Underhaug J, Kristensen T, Nielsen NC, Klintworth GK, Otzen DE, Enghild JJ. Human phenotypically distinct TGFBI corneal dystrophies are linked to the stability of the fourth FAS1 domain of TGFBIp. J Biol Chem 2011; 286:4951-8. [PMID: 21135107].
4. Karring H, Runager K, Thøgersen IB, Klintworth GK, Højrup P, Enghild JJ. Composition and proteolytic processing of corneal deposits associated with mutations in the TGFBI gene. Exp Eye Res 2012; 96:163-70. [PMID: 22155582].
5. Eifrig DE Jr, Afshari NA. Buchanan HW 4th, Bowling BL, Klintworth GK. Polymorphic corneal amyloidosis: a disorder due to a novel mutation in the transforming growth factor beta-induced (BIGH3) gene. Ophthalmology 2004; 111:1108-14. [PMID: 15177960].
6. Rappsilber J, Ishihama Y, Mann M. Stop and go extraction tips for matrix-assisted laser desorption/ionization, nanoelectrospray, and LC/MS sample pretreatment in proteomics. Anal Chem 2003; 75:663-70. [PMID: 12585499].
7. Perkins DN, Pappin DJ, Creasy DM, Cottrell JS. Probability-based protein identification by searching sequence databases using mass spectrometry data. Electrophoresis 1999; 20:3551-67. [PMID: 10612281].
8. Rappsilber J, Ryder U, Lamond AI, Mann M. Large-scale proteomic analysis of the human spliceosome. Genome Res 2002; 12:1231-45. [PMID: 12176931].
9. Karring H, Thøgersen IB, Klintworth GK, Møller-Pedersen T, Enghild JJ. A dataset of human cornea proteins identified by peptide mass fingerprinting and tandem mass spectrometry. Mol Cell Proteomics 2005; 4:1406-8. [PMID: 15911533].
10. Bern M, Phinney BS, Goldberg D. Reanalysis of Tyrannosaurus rex Mass Spectra. J Proteome Res 2009; 8:4328-32. [PMID: 19603827].
11. Craig R, Cortens JP, Beavis RC. Open source system for analyzing, validating, and storing protein identification data. J Proteome Res 2004; 3:1234-42. [PMID: 15595733].
12. Ishihama Y, Oda Y, Tabata T, Sato T, Nagasu T, Rappsilber J, Mann M. Exponentially modified protein abundance index (emPAI) for estimation of absolute protein amount in proteomics by the number of sequenced peptides per protein. Mol Cell Proteomics 2005; 4:1265-72. [PMID: 15958392].
13. Olsen JV, Ong SE, Mann M. Trypsin cleaves exclusively C-terminal to arginine and lysine residues. Mol Cell Proteomics 2004; 3:608-14. [PMID: 15034119].
14. Bergström J, Murphy C, Eulitz M, Weiss DT, Westermark GT, Solomon A, Westermark P. Codeposition of apolipoprotein A-IV and transthyretin in senile systemic (ATTR) amyloidosis. Biochem Biophys Res Commun 2001; 285:903-8. [PMID: 11467836].
15. Bergström J, Murphy CL, Weiss DT, Solomon A, Sletten K, Hellman U, Westermark P. Two different types of amyloid deposits-apolipoprotein A-IV and transthyretin-in a patient with systemic amyloidosis. Lab Invest 2004; 84:981-8. [PMID: 15146166].
16. Andreola A, Bellotti V, Giorgetti S, Mangione P, Obici L, Stoppini M, Torres J, Monzani E, Merlini G, Sunde M. Conformational switching and fibrillogenesis in the amyloidogenic fragment of apolipoprotein A-I. J Biol Chem 2003; 278:2444-51. [PMID: 12421824].
17. Glenner GG, Terry W, Harada M, Isersky C, Page D. Amyloid fibril proteins: proof of homology with immunoglobulin light chains by sequence analyses. Science 1971; 172:1150-1. [PMID: 4102463].
18. Engvig JP, Olsen KE, Gislefoss RE, Sletten K, Wahlstrom O, Westermark P. Constant region of a kappa III immunoglobulin light chain as a major AL-amyloid protein. Scand J Immunol 1998; 48:92-8. [PMID: 9714416].
19. Solomon A, Weiss DT, Murphy CL, Hrncic R, Wall JS, Schell M. Light chain-associated amyloid deposits comprised of a novel kappa constant domain. Proc Natl Acad Sci USA 1998; 95:9547-51. [PMID: 9689117].
20. Picken MM, Gallo GR, Pruzanski W, Frangione B. Biochemical characterization of amyloid derived from the variable region of the kappa light chain subgroup III. Arthritis Rheum 1990; 33:880-4. [PMID: 2114114].
21. Pepys MB, Hawkins PN, Booth DR, Vigushin DM, Tennent GA, Soutar AK, Totty N, Nguyen O, Blake CC, Terry CJ, Feest TG, Zalin AM, Hsuan JJ. Human lysozyme gene mutations cause hereditary systemic amyloidosis. Nature 1993; 362:553-7. [PMID: 8464497].
22. Frare E, Mossuto MF, Polverino de Laureto P, Dumoulin M, Dobson CM, Fontana A. Identification of the core structure of lysozyme amyloid fibrils by proteolysis. J Mol Biol 2006; 361:551-61. [PMID: 16859705].
23. Yanamandra K, Alexeyev O, Zamotin V, Srivastava V, Shchukarev A, Brorsson AC, Tartaglia GG, Vogl T, Kayed R, Wingsle G, Olsson J, Dobson CM, Bergh A, Elgh F, Morozova-Roche LA. Amyloid formation by the pro-inflammatory S100A8/A9 proteins in the ageing prostate. PLoS ONE 2009; 4:e5562-[PMID: 19440546].
24. Klintworth GK, Valnickova Z, Kielar RA, Baratz KH, Campbell RJ, Enghild JJ. Familial subepithelial corneal amyloidosis-a lactoferrin-related amyloidosis. Invest Ophthalmol Vis Sci 1997; 38:2756-63. [PMID: 9418728].
25. Ando Y, Nakamura M, Kai H, Katsuragi S, Terazaki H, Nozawa T, Okuda T, Misumi S, Matsunaga N, Hata K, Tajiri T, Shoji S, Yamashita T, Haraoka K, Obayashi K, Matsumoto K, Ando M, Uchino M. A novel localized amyloidosis associated with lactoferrin in the cornea. Lab Invest 2002; 82:757-66. [PMID: 12065686].
26. Araki-Sasaki K, Ando Y, Nakamura M, Kitagawa K, Ikemizu S, Kawaji T, Yamashita T, Ueda M, Hirano K, Yamada M, Matsumoto K, Kinoshita S, Tanihara H. Lactoferrin Glu561Asp facilitates secondary amyloidosis in the cornea. Br J Ophthalmol 2005; 89:684-8. [PMID: 15923502].
27. Coria F, Castano E, Prelli F, Larrondo-Lillo M, van Duinen S, Shelanski ML, Frangione B. Isolation and characterization of amyloid P component from Alzheimer's disease and other types of cerebral amyloidosis. Lab Invest 1988; 58:454-8. [PMID: 2965774].
28. Namba Y, Tomonaga M, Kawasaki H, Otomo E, Ikeda K. Apolipoprotein E immunoreactivity in cerebral amyloid deposits and neurofibrillary tangles in Alzheimer's disease and kuru plaque amyloid in Creutzfeldt-Jakob disease. Brain Res 1991; 541:163-6. [PMID: 2029618].
29. Yerbury JJ, Poon S, Meehan S, Thompson B, Kumita JR, Dobson CM, Wilson MR. The extracellular chaperone clusterin influences amyloid formation and toxicity by interacting with prefibrillar structures. FASEB J 2007; 21:2312-22. [PMID: 17412999].
30. MacRaild CA, Stewart CR, Mok YF, Gunzburg MJ, Perugini MA, Lawrence LJ, Tirtaatmadja V, Cooper-White JJ, Howlett GJ. Non-fibrillar components of amyloid deposits mediate the self-association and tangling of amyloid fibrils. J Biol Chem 2004; 279:21038-45. [PMID: 15031287].
31. Gallo G, Wisniewski T, Choi-Miura NH, Ghiso J, Frangione B. Potential role of apolipoprotein-E in fibrillogenesis. Am J Pathol 1994; 145:526-30. [PMID: 8080036].
32. Grau S, Baldi A, Bussani R, Tian X, Stefanescu R, Przybylski M, Richards P, Jones SA, Shridhar V, Clausen T, Ehrmann M. Implications of the serine protease HtrA1 in amyloid precursor protein processing. Proc Natl Acad Sci USA 2005; 102:6021-6. [PMID: 15855271].
33. Kanekiyo T, Ban T, Aritake K, Huang ZL, Qu WM, Okazaki I, Mohri I, Murayama S, Ozono K, Taniike M, Goto Y, Urade Y. Lipocalin-type prostaglandin D synthase/beta-trace is a major amyloid beta-chaperone in human cerebrospinal fluid. Proc Natl Acad Sci USA 2007; 104:6412-7. [PMID: 17404210].
34. Desai PP, Ikonomovic MD, Abrahamson EE, Hamilton RL, Isanski BA, Hope CE, Klunk WE, DeKosky ST, Kamboh MI. Apolipoprotein D is a component of compact but not diffuse amyloid-beta plaques in Alzheimer's disease temporal cortex. Neurobiol Dis 2005; 20:574-82. [PMID: 15916898].
35. Cáceres M, Suwyn C, Maddox M, Thomas JW, Preuss TM. Increased cortical expression of two synaptogenic thrombospondins in human brain evolution. Cereb Cortex 2007; 17:2312-21. [PMID: 17182969].
36. Bernstein HG, Rinne R, Kirschke H, Jarvinen M, Knofel B, Rinne A. Cystatin A-like immunoreactivity is widely distributed in human brain and accumulates in neuritic plaques of Alzheimer disease subjects. Brain Res Bull 1994; 33:477-81. [PMID: 8186992].
37. Rosenblatt DE, Geula C, Mesulam MM. Protease nexin I immunostaining in Alzheimer's disease. Ann Neurol 1989; 26:628-34. [PMID: 2554792].
38. Eikelenboom P, Stam FC. Immunoglobulins and complement factors in senile plaques. An immunoperoxidase study. Acta Neuropathol 1982; 57:239-42. [PMID: 6812382].
39. Bradt BM, Kolb WP, Cooper NR. Complement-dependent proinflammatory properties of the Alzheimer's disease beta-peptide. J Exp Med 1998; 188:431-8. [PMID: 9687521].
40. Johnson LV, Leitner WP, Rivest AJ, Staples MK, Radeke MJ, Anderson DH. The Alzheimer's A beta-peptide is deposited at sites of complement activation in pathologic deposits associated with aging and age-related macular degeneration. Proc Natl Acad Sci USA 2002; 99:11830-5. [PMID: 12189211].
41. Webster S, Lue LF, Brachova L, Tenner AJ, McGeer PL, Terai K, Walker DG, Bradt B, Cooper NR, Rogers J. Molecular and cellular characterization of the membrane attack complex, C5b-9, in Alzheimer's disease. Neurobiol Aging 1997; 18:415-21. [PMID: 9330973].
42. Snow AD, Mar H, Nochlin D, Kresse H, Wight TN. Peripheral distribution of dermatan sulfate proteoglycans (decorin) in amyloid-containing plaques and their presence in neurofibrillary tangles of Alzheimer's disease. J Histochem Cytochem 1992; 40:105-13. [PMID: 1370306].
43. Moss J, Shore I, Woodrow D. An ultrastructural study of the colocalization of biglycan and decorin with AA amyloid fibrils in human renal glomeruli. Amyloid 1998; 5:43-8. [PMID: 9547005].
44. Stokes MB, Holler S, Cui Y, Hudkins KL, Eitner F, Fogo A, Alpers CE. Expression of decorin, biglycan, and collagen type I in human renal fibrosing disease. Kidney Int 2000; 57:487-98. [PMID: 10652025].
45. Yousef GM, Magklara A, Chang A, Jung K, Katsaros D, Diamandis EP. Cloning of a new member of the human kallikrein gene family, KLK14, which is down-regulated in different malignancies. Cancer Res 2001; 61:3425-31. [PMID: 11309303].
46. Hooper JD, Bui LT, Rae FK, Harvey TJ, Myers SA, Ashworth LK, Clements JA. Identification and characterization of KLK14, a novel kallikrein serine protease gene located on human chromosome 19q13.4 and expressed in prostate and skeletal muscle. Genomics 2001; 73:117-22. [PMID: 11352573].
47. Baker JB, Low DA, Simmer RL, Cunningham DD. Protease-nexin: a cellular component that links thrombin and plasminogen activator and mediates their binding to cells. Cell 1980; 21:37-45. [PMID: 6157479].
48. Scott RW, Bergman BL, Bajpai A, Hersh RT, Rodriguez H, Jones BN, Barreda C, Watts S, Baker JB. Protease nexin. Properties and a modified purification procedure. J Biol Chem 1985; 260:7029-34. [PMID: 3997857].
49. Van Nostrand WE, McKay LD, Baker JB, Cunningham DD. Functional and structural similarities between protease nexin I and C1 inhibitor. J Biol Chem 1988; 263:3979-83. [PMID: 3279027].
50. Karring H, Runager K, Valnickova Z, Thøgersen IB, Møller-Pedersen T, Klintworth GK, Enghild JJ. Differential expression and processing of transforming growth factor beta induced protein (TGFBIp) in the normal human cornea during postnatal development and aging. Exp Eye Res 2010; 90:57-62. [PMID: 19788893].
51. Andersen RB, Karring H, Møller-Pedersen T, Valnickova Z, Thøgersen IB, Hedegaard CJ, Kristensen T, Klintworth GK, Enghild JJ. Purification and structural characterization of transforming growth factor beta induced protein (TGFBIp) from porcine and human corneas. Biochemistry 2004; 43:16374-84. [PMID: 15610032].
52. de Sousa MM, Vital C, Ostler D, Fernandes R, Pouget-Abadie J, Carles D, Saraiva MJ. Apolipoprotein AI and transthyretin as components of amyloid fibrils in a kindred with apoAI Leu178His amyloidosis. Am J Pathol 2000; 156:1911-7. [PMID: 10854214].
53. Bergström J, Patrosso MC, Colussi G, Salvadore M, Penco S, Lando G, Marocchi A, Ueda A, Nakamura M, Ando Y. A novel type of familial transthyretin amyloidosis, ATTR Asn124Ser, with co-localization of kappa light chains. Amyloid 2007; 14:141-5. [PMID: 17577687].
54. Johan K, Westermark G, Engstrom U, Gustavsson A, Hultman P, Westermark P. Acceleration of amyloid protein A amyloidosis by amyloid-like synthetic fibrils. Proc Natl Acad Sci USA 1998; 95:2558-63. [PMID: 9482925].
55. O'Nuallain B, Williams AD, Westermark P, Wetzel R. Seeding specificity in amyloid growth induced by heterologous fibrils. J Biol Chem 2004; 279:17490-9. [PMID: 14752113].
56. Jean L, Thomas B, Tahiri-Alaoui A, Shaw M, Vaux DJ. Heterologous amyloid seeding: revisiting the role of acetylcholinesterase in Alzheimer's disease. PLoS ONE 2007; 2:e652-[PMID: 17653279].
57. Yuan C, Berscheit HL, Huang AJ. Identification of an amyloidogenic region on keratoepithelin via synthetic peptides. FEBS Lett 2007; 581:241-7. [PMID: 17207483].
58. Tennstaedt A, Poepsel S, Truebestein L, Hauske P, Brockmann A, Schmidt N, Irle I, Sacca B, Niemeyer CM, Brandt R, Ksiezak-Reding H, Tirniceriu AL, Egensperger R, Baldi A, Dehmelt L, Kaiser M, Huber R, Clausen T, Ehrmann M. Human high temperature requirement serine protease A1 (HTRA1) degrades tau protein aggregates. J Biol Chem 2012; [PMID: 22535953].
59. Murwantoko YM, Ueta Y, Murasaki A, Kanda H, Oka C, Kawaichi M. Binding of proteins to the PDZ domain regulates proteolytic activity of HtrA1 serine protease. Biochem J 2004; 381:895-904. [PMID: 15101818].
60. Truebestein L, Tennstaedt A, Monig T, Krojer T, Canellas F, Kaiser M, Clausen T, Ehrmann M. Substrate-induced remodeling of the active site regulates human HTRA1 activity. Nat Struct Mol Biol 2011; 18:386-8. [PMID: 21297635].
61. Chamberland A, Wang E, Jones AR, Collins-Racie LA, LaVallie ER, Huang Y, Liu L, Morris EA, Flannery CR, Yang Z. Identification of a novel HtrA1-susceptible cleavage site in human aggrecan: evidence for the involvement of HtrA1 in aggrecan proteolysis in vivo. J Biol Chem 2009; 284:27352-9. [PMID: 19657146].
62. Borgono CA, Michael IP, Shaw JL, Luo LY, Ghosh MC, Soosaipillai A, Grass L, Katsaros D, Diamandis EP. Expression and functional characterization of the cancer-related serine protease, human tissue kallikrein 14. J Biol Chem 2007; 282:2405-22. [PMID: 17110383].
63. Brattsand M, Stefansson K, Lundh C, Haasum Y, Egelrud T. A proteolytic cascade of kallikreins in the stratum corneum. J Invest Dermatol 2005; 124:198-203. [PMID: 15654974].